Back to search
FDAFDA · Food and drugs·Recall number D-0298-2021

Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03

Published March 10, 2021 · Recall initiated: February 19, 2021

Summary

FDA records drug Class III recall D-0298-2021, published March 10, 2021 and initiated February 19, 2021. Recalling firm: Jubilant Cadista Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 635,400 cartons; Lot: Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals, Inc.
Distributor
USA nationwide, including Puerto Rico.
Lot
Lot #: 20K0043P, 20K0044P, 20K0042P, Exp 08/2022; 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P, Exp 09/2022
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Methylprednisolone Tablets USP, 4 MG, packaged in a 21-count blister pack, Rx only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-001-03 recalled?

Yes. FDA published recall D-0298-2021 on March 10, 2021. Reported hazard: Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

What should I do if I have this product?

Voluntary: Firm initiated · Letter